 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 08/11/2022 |
$20.51 |
$20.94 |
$19.76 |
$19.99 |
574.70K | | 08/12/2022 |
$20.22 |
$21.05 |
$19.99 |
$20.64 |
427.00K | | 08/15/2022 |
$20.52 |
$21.05 |
$20.31 |
$21.01 |
562.70K | | 08/16/2022 |
$21.21 |
$22.93 |
$20.46 |
$22.44 |
2.30M | | 08/17/2022 |
$22.14 |
$22.35 |
$21.35 |
$21.61 |
444.40K |
|
|
| Chinook Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Co.'s pipeline is focused on kidney diseases with clinical pathways. Co.'s lead clinical program is atrasentan, an endothelin A receptor antagonist. Co.'s second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in development for patients with IgA nephropathy. Co. developing CHK-336 for the treatment of primary hyperoxaluria as well as secondary hyperoxaluria and idiopathic kidney stone formation. Co. is also conducting research programs in several other rare, severe chronic kidney diseases. | |
|
Chinook Therapeutics (KDNY) has the following price history information. Looking back at KDNY historical stock prices for the last five trading days, on August 11, 2022, KDNY opened at $20.51, traded as high as $20.94 and as low as $19.76, and closed at $19.99. Trading volume was a total of 574.70K shares. On August 12, 2022, KDNY opened at $20.22, traded as high as $21.05 and as low as $19.99, and closed at $20.64. Trading volume was a total of 427.00K shares. On August 15, 2022, KDNY opened at $20.52, traded as high as $21.05 and as low as $20.31, and closed at $21.01. Trading volume was a total of 562.70K shares. On August 16, 2022, KDNY opened at $21.21, traded as high as $22.93 and as low as $20.46, and closed at $22.44. Trading volume was a total of 2.30M shares. On August 17, 2022, KDNY opened at $22.14, traded as high as $22.35 and as low as $21.35, and closed at $21.61. Trading volume was a total of 444.40K shares.
KDNY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Chinook Therapeutics shares, starting with a $10,000 purchase of KDNY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/16/2015 |
|
| End date: |
08/17/2022 |
|
| Start price/share: |
$39.40 |
|
| End price/share: |
$21.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-45.15% |
|
| Average Annual Total Return: |
-7.85% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,486.66 |
|
| Years: |
7.34 |
|
|
|
| Date |
Close |
| 08/11/2022 | $19.99 | | 08/12/2022 | $20.64 | | 08/15/2022 | $21.01 | | 08/16/2022 | $22.44 | | 08/17/2022 | $21.61 |
|
|
Free KDNY Email Alerts:
